Versartis Inc (NASDAQ:VSAR)

1.50
Delayed Data
As of 11:56am ET
 -0.05 / -3.23%
Today’s Change
1.35
Today|||52-Week Range
22.10
-31.82%
Year-to-Date
No recent news for Versartis Inc.

Today’s Trading

Previous close1.55
Today’s open1.55
Day’s range1.50 - 1.55
Volume85,336
Average volume (3 months)460,927
Market cap$54.1M
Data as of 11:56am ET, 05/21/2018

Growth & Valuation

Earnings growth (last year)+22.51%
Earnings growth (this year)-68.05%
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales1.94
Price/Book0.65

Competitors

 Today’s
change
Today’s
% change
HSKAHeska Corp-0.45-0.44%
PRTKParatek Pharmaceutic...-0.20-1.74%
AMPHAmphastar Pharmaceut...-0.05-0.30%
RETAReata Pharmaceutical...+0.13+0.41%
Data as of 12:11pm ET, 05/21/2018

Financials

Next reporting dateAugust 7, 2018
EPS forecast (this quarter)-$0.96
Annual revenue (last year)$40.0M
Annual profit (last year)-$85.0M
Net profit margin-212.45%

Profile

Sector
Health Technology
Industry
Biotechnology
President, CEO, CFO &
Director
Jay P. Shepard
Chief Medical Officer, Head-Clinical &
Medical
Robert Gut
Corporate headquarters
Menlo Park, California

Forecasts